Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

LENSAR, Inc. - Common Stock (NQ: LNSR )

14.60 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 13, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 320
Open 14.60
Bid (Size) 14.54 (2)
Ask (Size) 15.30 (2)
Prev. Close 14.60
Today's Range 14.60 - 14.60
52wk Range 2.670 - 16.40
Shares Outstanding 11,102,611
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
LENSAR - Top Healthcare Equipment Stock
LENSAR, Inc., a commercial-stage medical device company. 
Via Talk Markets
Topics Stocks / Equities
LENSAR Reports Fourth Quarter and Full Year 2024 Results and Provides Business Update
31 ALLY Robotic Cataract Laser Systems™ placed in Q4 2024, representing an 86% increase in ALLY placements in full year 2024 over 2023; Company’s total installed systems increased to approximately 385... 
Via FinancialNewsMedia

Performance

YTD
+68.01%
+68.01%
1 Month
+42.58%
+42.58%
3 Month
+89.36%
+89.36%
6 Month
+190.84%
+190.84%
1 Year
+250.96%
+250.96%

More News

Read More
Earnings Scheduled For February 27, 2025
Via Benzinga
LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From LENSAR, Inc.
Via Business Wire
LENSAR to Participate in Two Upcoming Investor Conferences
From LENSAR, Inc.
Via Business Wire
Earnings Preview: LENSAR
Via Benzinga
LNSR Stock Earnings: LENSAR Misses EPS, Beats Revenue for Q2 2024
Via InvestorPlace
LENSAR Reports Second Quarter 2024 Results and Provides Business Update
From LENSAR, Inc.
Via Business Wire
LENSAR Announces Certification for the ALLY® Adaptive Cataract Treatment System in the European Union
From LENSAR, Inc.
Via Business Wire
LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From LENSAR, Inc.
Via Business Wire
LENSAR to Report Second Quarter 2024 Financial Results on Thursday, August 8, 2024
From LENSAR, Inc.
Via Business Wire
3 Under-$10 Stocks With the Potential to Make You a Millionaire
Via InvestorPlace
LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From LENSAR, Inc.
Via Business Wire
LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From LENSAR, Inc.
Via Business Wire
LENSAR to Participate in the 2024 Leerink Partners Healthcare Crossroads Conference
From LENSAR, Inc.
Via Business Wire
LNSR Stock Earnings: LENSAR Beats EPS, Beats Revenue for Q1 2024
Via InvestorPlace
LENSAR Reports First Quarter 2024 Results and Provides Business Update
From LENSAR, Inc.
Via Business Wire
LENSAR to Report First Quarter 2024 Financial Results on Thursday, May 9, 2024
From LENSAR, Inc.
Via Business Wire
LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From LENSAR, Inc.
Via Business Wire
LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From LENSAR, Inc.
Via Business Wire
LENSAR Reports Fourth Quarter and Full Year 2023 Results and Provides Business Update
From LENSAR, Inc.
Via Business Wire
Earnings Scheduled For March 4, 2024
Via Benzinga
LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From LENSAR, Inc.
Via Business Wire
LENSAR to Report Fourth Quarter and Full Year 2023 Financial Results on Monday, March 4, 2024
From LENSAR, Inc.
Via Business Wire
LENSAR Reports Third Quarter 2023 Results and Provides Business Update
From LENSAR, Inc.
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.